본문 바로가기 대메뉴 바로가기

진료과 검색

충북대학교병원 로고
게시물 검색
의료진 찾기

[총 0명이 검색되었습니다.]

혈액종양내과

권지현 교수

전문분야

백혈병, 골수이형성증후군, 빈혈, 기타 혈액질환

진료일정

원모양 외래 삼각형모양 클리닉
테이블 자료 : 진료시간, 오전, 오후, 요일별 가능날짜 정보제공
월 화 수 목 금
오전 진료 진료
오후 진료 진료
비고 -
학회 및 출장등의 이유로 실제 진료스케줄과 차이가 있을 수 있습니다.
진료예약
권지현 교수

충북대학교병원 X 혈액종양내과

의료진 한마디

학력 및 경력

  • 서울대학교 의과대학 의학사
  • 서울대학교 의과대학 의학석사
  • 서울대학교 의과대학 의학박사
  • 서울대학교병원 내과 전공의 과정 수료
  • 서울대학교병원 혈액종양내과 전임의 과정 수료
  • 서울대학교병원 혈액종양내과 진료교수
  • 현 충북대학교 의과대학 부교수

학회활동

  • 미국혈액학회 정회원
  • 대한암학회 정회원
  • 한국임상암학회 정회원
  • 대한조혈모세포이식학회 정회원
  • 대한혈액학회 정회원
  • 대한내과학회 정회원
논문연구실적 - 발표년도, 논문명 정보 제공
발표년도 제목
2022 Diagnostic Value of Ascitic Tumor Markers for GastricCancer-associated Malignant Ascites. Korean Journal of Helicobacter UpperGastrointestinal Research 2022;22(1):38-49 2022 Limited benefits of thalidomide and dexamethasonemaintenance after autologous stem cell transplantationin newly diagnosed multiple myeloma patients:aprospective phase II multi-center study in Korea. CURRENT PROBLEMS IN CANCER 2022;46(1):1-9 2022 A case report of nilotinib-induced irreversible interstitiallung disease. MEDICINE 2022;101(4):- 2021 Real?world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis. Cancer Communications 2021 2021 The Prognostic Ability of RAS Pathway-Related GeneMutations in Patients with Myeloid Neoplasms Treatedwith Hypomethylating Agents. ACTA HAEMATOLOGICA 2021;144(6):649-659 2021 E-Cadherin and Angiopoietin-2 as Potential Biomarkersfor Colorectal Cancer With Peritoneal Carcinomatosis. ANTICANCER RESEARCH 2021;41(9):4497-4504 2021 Effects of Video Based Information Provision Using aSmart Pad on Patients Undergoing Bone Marrow Biopsy. CLINICAL NURSING RESEARCH 2021;30(6):724-733 2021 Diagnosis and treatment of chronic myelomonocyticleukemia. Blood Research 2021;56(S1):S5-S16 2021 Real-world outcomes of ibrutinib therapy in Koreanpatients with relapsed or refractory mantle celllymphoma: a multicenter, retrospective analysis. CANCER COMMUNICATIONS 2021;41(3):275-278 2020  Pilot Study of Aerosolised Plus Intravenous Vancomycin in Mechanically Ventilated Patients with Methicillin-Resistant Staphylococcus Aureus Pneumonia.  Cancer Medicine {2020} 2020 Genetic Features of Lung Adenocarcinoma with Ground-Glass Opacity: What Causes the Invasiveness of Lung Adenocarcinoma? . Cancer Research and Treatment {2020} 2020 Germline JAK2 V617F mutation as a susceptibility genecausing myeloproliferative neoplasm in first-degreerelatives. LEUKEMIA & LYMPHOMA 2020;61(13):3251-3254 2020 Differences in diagnosis, treatment, and survival rate ofacute myeloid leukemia with or without disabilities: Anational cohort study in the Republic of Korea. CANCER MEDICINE 2020;9(15):5335-5344 2020 The Effect of Disability on the Diagnosis and Treatmentof Multiple Myeloma in Korea: A National Cohort Study. CANCER RESEARCH AND TREATMENT 2020;52(1):1-9 2019 Afatinib Overcomes Pemetrexed-Acquired Resistance inNon-Small Cell Lung Cancer Cells Harboring anEML4-ALK Rearrangement. Cells 2019;8(12):- 2019 A Case of Acquired Amegakaryocytic Thrombocytopeniawith Anti-c-mpl Autoantibody: Comparison withIdiopathic Thrombocytopenic Purpura. ACTA HAEMATOLOGICA 2019;142(4):239-243 2019 Exosomal miR-181b-5p Downregulation in AscitesServes as a Potential Diagnostic Biomarker for GastricCancer-associated Malignant Ascites. JOURNAL OF GASTRIC CANCER 2019;19(3):301-314 2019 Exosomal miR-181b-5p Downregulation in AscitesServes as a Potential Diagnostic Biomarker for GastricCancer-associated Malignant Ascites. JOURNAL OF GASTRIC CANCER 2019;19(3):301-314 2018 Long-term Survival after Repeated Local Therapy and Salvage Chemotherapy for Recurrent Metastases from Gastric Cancer: a Case Report and Literature Review. J gastric cancer {2018} 2018 Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study. Supportive Care in Cancer {2018} 2018 Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications. Thrombosis research {2018} 2018 Feasibility and accessibility of electronic patient-reportedoutcome measures using a smartphone during routinechemotherapy: a pilot study. SUPPORTIVE CARE IN CANCER 2018;26(11):3721-3728 2018 No benefit of hypomethylating agents compared tosupportive care for higher risk myelodysplastic syndrome. KOREAN JOURNAL OF INTERNALMEDICINE 2018;33(6):1194-1202 2018 Long-term Survival after Repeated Local Therapy andSalvage Chemotherapy for Recurrent Metastases fromGastric Cancer: a Case Report and Literature Review. JOURNAL OF GASTRIC CANCER 2018;18(3):305-312 2018 EGFR Mutation Status in LungAdenocarcinoma-Associated Malignant Pleural Effusionand Efficacy of EGFR Tyrosine Kinase Inhibitors. CANCER RESEARCH AND TREATMENT 2018;50(3):908-916 2018 Low-molecular-weight heparin treatment for portal veinthrombosis in liver cirrhosis: Efficacy and the risk ofhemorrhagic complications. THROMBOSIS RESEARCH 2018;163():71-76 2017 Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo- Controlled, Phase 2 Trial . PLOS One {2017} 2017 Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia. Journal of Clinical Oncology {2017} 2017 Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/ refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study. Cancer Medicine {2017} 2017 Prospective Randomized Comparison of Idarubicin andHigh-Dose Daunorubicin in Induction Chemotherapy forNewly Diagnosed Acute Myeloid Leukemia. JOURNAL OF CLINICAL ONCOLOGY 2017;35(24):2754-2754 2017 A Case of Pulmonary Langerhans Cell SarcomaSimultaneously Diagnosed with Cutaneous LangerhansCell Histiocytosis Studied by Whole-Exome Sequencing. ACTA HAEMATOLOGICA 2017;138(1):24-30 2017 Efficacy and toxicity of the combination chemotherapyof thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the KoreanMultiple Myeloma Working Party (KMMWP)retrospective study. CANCER MEDICINE 2017;6(1):100-108
번호, 진료언론사, 보도명, 보도일자 정보제공
번호 언론사 보도명 보도일자